US Patent Issued to Virginia Commonwealth University on July 15 for "Lipidic analogs of anti-cancer stem cell agent" (Virginia Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,941, issued on July 15, was assigned to Virginia Commonwealth University (Richmond, Va.).

"Lipidic analogs of anti-cancer stem cell agent" was invented by Umesh R. Desai (Richmond, Va.), Balaji Nagarajan (Richmond, Va.), Connor O'Hara (Richmond, Va.), Daniel Kwame Afosah (Richmond, Va.), Elsamani I. Abdelfadiel (Richmond, Va.), Jyothi Sistla (Richmond, Va.), Rahaman Navaz Gangji (Richmond, Va.), Ravikumar Ongolu (Richmond, Va.), Shravan Morla (Richmond, Va.), Viji Sankaranarayanan (Richmond, Va.), Bhaumik B. Patel (Richmond, Va.), Chetna Sharon (Richmond, Va.), Rio Boothello (Richmond, Va.) and Alberto Vera (Richmond, Va.).

According to the abstract* released by the U.S. Patent &...